in the biliary and pancreatic ducts as high signal intensity on T2‐weighted sequences; it is
the newest modality for biliary and pancreatic duct imaging. MRCP is of proven utility in a
variety of biliary and pancreatic diseases, including choledocholithiasis, congenital
anatomic variants, chronic pancreatitis, post‐cholecystectomy disorders, and neoplastic duct
obstruction. MRCP is an evolving technique, but it has reached the stage of development …